Sol-Gel Technologies Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SLGL | FBIO | CUVL | YDES | MDWD | PVLA | |
|---|---|---|---|---|---|---|
| Market cap | 216.08M | 65.70M | 247.39M | 492.28M | 183.33M | 2.34B |
| P/E (TTM) | — | 0.7 | 10.9 | — | — | — |
| Forward P/E | -8.2 | -1.1 | — | — | -6.2 | -20.5 |
| Price/book | 4.5 | 0.4 | 1.3 | 110.3 | 5.1 | 10.8 |
| Dividend yield | — | — | 0.70% | — | — | — |
| 1-year change | +95.14% | −21.77% | −31.75% | −39.33% | −26.23% | +101.89% |
| Today | +3.43% | +1.55% | −3.45% | +7.84% | +6.05% | +6.11% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SLGL news ›Chemists develop compounds capable of forming heath-resistant, economic and biocompatible gels
Eating a yogurt or a jelly, using a pharmaceutical or cosmetic cream or shampoo are just some of the numerous everyday actions in which we use gels developed through a process of gelation. Researchers have now developed a new family of…
HC Wainwright & Co. reiterates Buy rating on Microbot Medical, $12 price target
TradingView HC Wainwright & Co. reiterates Buy rating on Microbot Medical, $12 price target HC Wainwright & Co. reiterated their Buy rating on Microbot Medical's stock with a price target of $12.00. The price target imp
Gelion takes step closer to commerciality with latest lab result
Proactive has a commercial relationship with Gelion PLC. This article was produced independently under Proactive's Editorial Standards Policy. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) told investors it has taken another step towards…
Sol-Gel Technologies (NASDAQ:SLGL) Stock Keeps “Buy” Rating at HC Wainwright
Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently…
Sol-Gel Technologies (NASDAQ:SLGL) & Iterum Therapeutics (NASDAQ:ITRM) Head to Head Review
Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of…
Sol-Gel Technologies Ltd. (SLGL) Analyst/Investor Day - Slideshow
2026-10-15. The following slide deck was published by Sol-Gel Technologies Ltd. The following slide deck was published by Sol-Gel Technologies Ltd. in conjunction with this event.
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net5
- seekingalpha.com2
- financialcontent.com1
- proactiveinvestors.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.